mucosal immunity
Showing 1 - 25 of 3,195
Infectious Viral Load: a Prospective Observational Study
Recruiting
- SARS-CoV-2 Infection
- +3 more
- No intervention
-
Geneva, SwitzerlandGeneva University Hospital
Mar 20, 2023
COVID-19 Trial (Blood sample collection, Saliva sample collection, Nasopharyngeal and nasal sample collection)
Not yet recruiting
- COVID-19
- Blood sample collection
- +3 more
- (no location specified)
May 12, 2023
Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2
Recruiting
- Influenza
- COVID-19
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 13, 2022
Yogurt Intake, Gastrointestinal Immune Function, Gut Microbiome Trial in Davis (Yogurt Intervention)
Not yet recruiting
- Yogurt Intake
- +3 more
- Yogurt Intervention
-
Davis, CaliforniaUSDA Western Human Nutrition Research Center
Jun 26, 2023
Gonorrhoea Trial in Decatur (Meningococcal Group B Vaccine, Placebo)
Recruiting
- Gonorrhoea
- Meningococcal Group B Vaccine
- Placebo
-
Decatur, GeorgiaEmory Vaccine Center - The Hope Clinic
Feb 2, 2023
Systemic and Nasal Mucosal Immunity After Influenza Vaccination
Active, not recruiting
- Influenza Immunity
-
Bethesda, MarylandNational Institute of Allergy and Infectious Diseases (NIAID)
Jul 6, 2022
The Dynamic Process of VMB and Mucosal Immunity After FUS
Recruiting
- Cervical Intraepithelial Neoplasia
- Focused Ultrasound
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Aug 16, 2022
Oral Microbiome & Mucosal Immunity in COVID-19 Disease
Not yet recruiting
- COVID-19
- +5 more
- COVID infection
- +2 more
-
London, United KingdomKing's College London
Jan 26, 2022
Asthma, Allergic Rhinitis, Cat Allergy Trial (Research Grade RG-RV)
Not yet recruiting
- Asthma
- +3 more
- Research Grade RG-RV
- (no location specified)
Aug 30, 2022
Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))
Not yet recruiting
- Mumps
- +2 more
- MMR booster vaccination (as M-M-R-VaxPro)
-
Zürich, SwitzerlandEpidemiology, Biostatistics and Prevention Institute University
Jun 8, 2023
Typhoid Fever, Paratyphoid Fever Trial in Oxford (Salmonella Typhi, Salmonella Paratyphi)
Completed
- Typhoid Fever
- Paratyphoid Fever
- Salmonella Typhi
- Salmonella Paratyphi
-
Oxford, Oxfordshire, United KingdomOxford Vaccine Group
May 30, 2022
Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19
Completed
- SARS-CoV-2 Infection
- nasopharyngeal and throat swab
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Jan 28, 2021
Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva
Not yet recruiting
- Covid19
- Blood- and saliva tests
- (no location specified)
Apr 12, 2021
HIV Trial in Bronx (Tenofovir gel, Tenofovir gel )
Completed
- HIV Infections
- Tenofovir gel
- Tenofovir gel placebo
-
Bronx, New YorkAlbert Einstein College of Medicine - East Campus GCRC (Herold)
Oct 28, 2021
Influenza Trial run by the NIAID (Flucelvax(R), Human Challenge virus)
Completed
- Influenza
- Flucelvax(R)
- Human Challenge virus
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 7, 2020
Certain Disorders Involving the Immune Mechanism Trial in Tours (Sampling, PCR (polymerase chain reaction) SARS-CoV-2)
Not yet recruiting
- Certain Disorders Involving the Immune Mechanism
- Sampling
- PCR (polymerase chain reaction) SARS-CoV-2
-
Tours, FranceCHRU de Tours
Nov 17, 2023
Poliomyelitis Trial (nOPV2)
Not yet recruiting
- Poliomyelitis
- nOPV2
- (no location specified)
Dec 22, 2022
Poliomyelitis Trial (Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant
Recruiting
- Poliomyelitis
- Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant heat labile toxin, LT(R192G/L211A), (dmLT)
- +2 more
-
Burlington, VermontUniversity of Vermont Vaccine Testing Center at the Larner Colle
Sep 2, 2022
Epidemiological, Clinical and Biological Caracteristics of
Recruiting
- Meningococcal Infections
- There is no intervention
-
Poitiers, Vienne, FrancePoitiers University
Aug 8, 2023
FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at
Recruiting
- Monkeypox
-
Antwerp, BelgiumInstitute of Tropical Medicine
May 19, 2023
COVID-19 Infection Trial in ¨Paris (serology test, nasopharyngeal swab, rectal swab)
Completed
- COVID-19 Infection
- serology test
- +3 more
-
¨Paris, FranceHôpital necker Enfants-Malades
Feb 1, 2023
HIV Trial in Rochester (HIV p17/p24:Ty-VLP, Aluminum hydroxide)
Completed
- HIV Infections
- HIV p17/p24:Ty-VLP
- Aluminum hydroxide
-
Rochester, New YorkUniv. of Rochester AVEG
Oct 28, 2021
HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein
Completed
- HIV Infections
- MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
- +2 more
-
Birmingham, Alabama
- +5 more
Oct 27, 2021
Immune Response to C.Difficile Infection
Recruiting
- Clostridium Difficile
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 31, 2022
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022